Trial Profile
Cost-effectiveness of bazedoxifene and raloxifene for the treatment of postmenopausal osteoporosis in Europe
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2012
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary) ; Raloxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 05 Apr 2012 New trial record
- 24 Mar 2012 Results presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.